Clinical Trial Update: Mycophenolate Mofetil, Carnitine and PDE5 Inhibitor, Three Potential Treatments for Resistant Proteinuria Slowing Diabetic Nephropathy Deterioration [NA]

View source ↗

Summary

Overview of an ongoing clinical trial evaluating mycophenolate mofetil, carnitine, and a PDE5 inhibitor as potential treatments to slow deterioration in diabeti…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• Diabetic Nephropathy

Drugs mentioned

• Carnitine (L-carnitine)
• MYCOPHENOLATE MOFETIL (MYCOPHENOLATE MOFETIL)
• PDE5 inhibitor (unspecified)

Snippet

Sponsor: The Nazareth Hospital, Israel | Conditions: Diabetic Nephropathy, Chronic Kidney Disease | NA | Status: UNKNOWN